Simone M. Shurland

687 total citations
16 papers, 552 citations indexed

About

Simone M. Shurland is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Simone M. Shurland has authored 16 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 7 papers in Epidemiology and 6 papers in Clinical Biochemistry. Recurrent topics in Simone M. Shurland's work include Antimicrobial Resistance in Staphylococcus (10 papers), Bacterial Identification and Susceptibility Testing (6 papers) and Antibiotic Use and Resistance (4 papers). Simone M. Shurland is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (10 papers), Bacterial Identification and Susceptibility Testing (6 papers) and Antibiotic Use and Resistance (4 papers). Simone M. Shurland collaborates with scholars based in United States, Trinidad and Tobago and Jamaica. Simone M. Shurland's co-authors include Mary‐Claire Roghmann, Min Zhan, Douglas D. Bradham, J. Kristie Johnson, Fitzroy A. Orrett, O. Colin Stine, Anthony D. Harris, Kristen Kreisel, Mamuka Kotetishvili and J. Glenn Morris and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Emerging infectious diseases and Archives of Physical Medicine and Rehabilitation.

In The Last Decade

Simone M. Shurland

16 papers receiving 532 citations

Peers

Countries citing papers authored by Simone M. Shurland

Since Specialization

Citations

This map shows the geographic impact of Simone M. Shurland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simone M. Shurland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simone M. Shurland more than expected).

Fields of papers citing papers by Simone M. Shurland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simone M. Shurland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simone M. Shurland. The network helps show where Simone M. Shurland may publish in the future.

Co-authorship network of co-authors of Simone M. Shurland

This figure shows the co-authorship network connecting the top 25 collaborators of Simone M. Shurland. A scholar is included among the top collaborators of Simone M. Shurland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simone M. Shurland. Simone M. Shurland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Flexible Development Programs for Antibacterial Drugs to Address Unmet Medical Needs 2024 ·Emerging infectious diseases ·(unknown), (unknown), Xiaojing Qi, Daniel B. Rubin, Simone M. Shurland, Avery Goodwin, Xiaohui Wei, (unknown), (unknown), Terry J. Miller, Peter Kim, Adam Sherwat	1
2	FDA Public Workshop Summary: Advancing Animal Models for Antibacterial Drug Development 2020 ·Antimicrobial Agents and Chemotherapy ·(unknown), (unknown), Edward A. Weinstein, Abhay Joshi, Simone M. Shurland, (unknown), Jürgen B. Bulitta, Binh An Diep, Tína Guina, William Hope, Matthew B. Lawrenz, Alexander J. Lepak, Brian Luna, Lynn Miesel, Andrew J. Phipps, Thomas J. Walsh, Jason Weiss, (unknown), John Farley	13
3	Community-associated Methicillin-resistant Staphylococcus aureusBacteremia and Endocarditis among HIV Patients: A cohort study 2011 ·BMC Infectious Diseases ·Jon P. Furuno, J. Kristie Johnson, Marin L. Schweizer, (unknown), O. Colin Stine, Simone M. Shurland, Graeme N. Forrest	38
4	Comparison of the Methicillin-Resistant Staphylococcus aureus Acquisition among Rehabilitation and Nursing Home Residents 2011 ·Infection Control and Hospital Epidemiology ·Jon P. Furuno, Simone M. Shurland, Min Zhan, J. Kristie Johnson, Richard A. Venezia, Anthony D. Harris, Mary‐Claire Roghmann	28
5	Comparison of the Methicillin-Resistant Staphylococcus aureus Acquisition among Rehabilitation and Nursing Home Residents 2011 ·Infection Control and Hospital Epidemiology ·Jon P. Furuno, Simone M. Shurland, Min Zhan, J. Kristie Johnson, Richard A. Venezia, Anthony D. Harris, Mary‐Claire Roghmann	3
6	USA300 methicillin-resistant S. aureus (USA300 MRSA) colonization and the risk of MRSA infection in residents of extended-care facilities 2011 ·Epidemiology and Infection ·Simone M. Shurland, O. Colin Stine, Richard A. Venezia, Min Zhan, Jon P. Furuno, Ram R. Miller, Mary‐Claire Roghmann	5
7	Prolonged Colonization with the Methicillin-Resistant Staphylococcus aureus Strain USA300 among Residents of Extended Care Facilities 2010 ·Infection Control and Hospital Epidemiology ·Simone M. Shurland, O. Colin Stine, Richard A. Venezia, J. Kristie Johnson, Min Zhan, Jon P. Furuno, Ram R. Miller, Colleen Pelser, Mary‐Claire Roghmann	2
8	Colonization Sites of USA300 Methicillin-ResistantStaphylococcus aureusin Residents of Extended Care Facilities 2009 ·Infection Control and Hospital Epidemiology ·Simone M. Shurland, O. Colin Stine, Richard A. Venezia, J. Kristie Johnson, Min Zhan, Jon P. Furuno, Ram R. Miller, Tamara M. Johnson, Mary‐Claire Roghmann	22
9	Staphylococcus aureus Colonization in Community-Dwelling People With Spinal Cord Dysfunction 2007 ·Archives of Physical Medicine and Rehabilitation ·Mary‐Claire Roghmann, Peter H. Gorman, Mitchell T. Wallin, Kristen Kreisel, Simone M. Shurland, Judith A. Johnson	7
10	Comparison of Mortality Risk Associated With Bacteremia Due to Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus 2007 ·Infection Control and Hospital Epidemiology ·Simone M. Shurland, Min Zhan, Douglas D. Bradham, Mary‐Claire Roghmann	195
11	How important is patient-to-patient transmission in extended-spectrum β-lactamase Escherichia coli acquisition 2007 ·American Journal of Infection Control ·Anthony D. Harris, Mamuka Kotetishvili, Simone M. Shurland, Judy A. Johnson, J. Glenn Morris, (unknown), J. Kristie Johnson	98
12	Skin and Soft Tissue Infections Caused by Methicillin-ResistantStaphylococcus aureusUSA300 Clone 2007 ·Emerging infectious diseases ·J. Kristie Johnson, (unknown), Simone M. Shurland, Kristen Kreisel, O. Colin Stine, Mary‐Claire Roghmann	85
13	Neonatal sepsis and mortality in a regional hospital in Trinidad: aetiology and risk factors 2001 ·Annals of Tropical Paediatrics ·Fitzroy A. Orrett, Simone M. Shurland	23
14	Knowledge and Awareness of Tuberculosis Among Pre-University Students in Trinidad 2001 ·Journal of Community Health ·Fitzroy A. Orrett, Simone M. Shurland	6
15	Prevalence of bacterial pathogens and susceptibility patterns from clinical sources in Trinidad. 2000 ·PubMed ·Fitzroy A. Orrett, Simone M. Shurland	9
16	Significance of coagulase-negative staphylococci in urinary tract infections in a developing country. 1998 ·PubMed ·Fitzroy A. Orrett, Simone M. Shurland	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact